Decentralized CAR-T Manufacturing Could Expand Access and Cut Costs
A WBMT review examines point-of-care CAR-T manufacturing, shorter vein-to-vein times, lower production costs, and the regulatory hurdles to scale.
This section contains the website’s posts.